Neurodegenerative diseases and effective drug delivery: A review of challenges and novel therapeutics
Amna Akhtar
1, 2
,
Anisa Andleeb
3
,
Tayyba Sher Waris
3
,
Maasoomeh Bazzar
4
,
Alireza Moradi
5, 6
,
Nasir Raza Awan
7, 8
,
Muhammad Yar
3
7
Department of Neurosciences, Sharif Medical and Dental College, Lahore, Pakistan
|
8
Spinacure, 63-A Block E1, Gulberg III, Lahore, Pakistan.
|
Publication type: Journal Article
Publication date: 2021-02-01
scimago Q1
wos Q1
SJR: 2.470
CiteScore: 19.4
Impact factor: 11.5
ISSN: 01683659, 18734995
PubMed ID:
33197487
Pharmaceutical Science
Abstract
The central nervous system (CNS) encompasses the brain and spinal cord and is considered the processing center and the most vital part of human body. The central nervous system (CNS) barriers are crucial interfaces between the CNS and the periphery. Among all these biological barriers, the blood-brain barrier (BBB) strongly impede hurdle for drug transport to brain. It is a semi-permeable diffusion barrier against the noxious chemicals and harmful substances present in the blood stream and regulates the nutrients delivery to the brain for its proper functioning. Neurological diseases owing to the existence of the BBB and the blood-spinal cord barrier have been terrible and threatening challenges all over the world and can rarely be directly mediated. In fact, drug delivery to brain remained a challenge in the treatment of neurodegenerative (ND) disorders, for these different approaches have been proposed. Nano-fabricated smart drug delivery systems and implantable drug loaded biomaterials for brain repair are among some of these latest approaches. In current review, modern approaches developed to deal with the challenges associated with transporting drugs to the CNS are included. Recent studies on neural drug discovery and injectable hydrogels provide a potential new treatment option for neurological disorders. Moreover, induced pluripotent stem cells used to model ND diseases are discussed to evaluate drug efficacy. These protocols and recent developments will enable discovery of more effective drug delivery systems for brain.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
4
5
|
|
|
International Journal of Molecular Sciences
5 publications, 2.69%
|
|
|
Pharmaceutics
4 publications, 2.15%
|
|
|
Ageing Research Reviews
4 publications, 2.15%
|
|
|
Journal of Drug Delivery Science and Technology
4 publications, 2.15%
|
|
|
International Journal of Biological Macromolecules
4 publications, 2.15%
|
|
|
Molecules
3 publications, 1.61%
|
|
|
Pharmaceuticals
3 publications, 1.61%
|
|
|
Journal of Controlled Release
3 publications, 1.61%
|
|
|
Biomaterials
3 publications, 1.61%
|
|
|
International Journal of Pharmaceutics
3 publications, 1.61%
|
|
|
Advanced healthcare materials
3 publications, 1.61%
|
|
|
Biomedicines
3 publications, 1.61%
|
|
|
Nanomaterials
2 publications, 1.08%
|
|
|
Metabolic Brain Disease
2 publications, 1.08%
|
|
|
Biomedicine and Pharmacotherapy
2 publications, 1.08%
|
|
|
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology
2 publications, 1.08%
|
|
|
ACS applied materials & interfaces
2 publications, 1.08%
|
|
|
Molecular Pharmaceutics
2 publications, 1.08%
|
|
|
Advanced Materials
2 publications, 1.08%
|
|
|
ACS Applied Bio Materials
2 publications, 1.08%
|
|
|
Regenerative Engineering and Translational Medicine
2 publications, 1.08%
|
|
|
Advanced Therapeutics
2 publications, 1.08%
|
|
|
Functionalized Smart Nanomaterials for Point-of-Care Testing
2 publications, 1.08%
|
|
|
AAPS PharmSciTech
2 publications, 1.08%
|
|
|
Journal of Dispersion Science and Technology
2 publications, 1.08%
|
|
|
Molecular Biology Reports
2 publications, 1.08%
|
|
|
Polymers
1 publication, 0.54%
|
|
|
APL Bioengineering
1 publication, 0.54%
|
|
|
Antioxidants and Redox Signaling
1 publication, 0.54%
|
|
|
1
2
3
4
5
|
Publishers
|
10
20
30
40
50
60
|
|
|
Elsevier
56 publications, 30.11%
|
|
|
Springer Nature
42 publications, 22.58%
|
|
|
MDPI
27 publications, 14.52%
|
|
|
Wiley
21 publications, 11.29%
|
|
|
American Chemical Society (ACS)
9 publications, 4.84%
|
|
|
Taylor & Francis
8 publications, 4.3%
|
|
|
Royal Society of Chemistry (RSC)
5 publications, 2.69%
|
|
|
Frontiers Media S.A.
3 publications, 1.61%
|
|
|
IGI Global
2 publications, 1.08%
|
|
|
Apex Publishing
2 publications, 1.08%
|
|
|
AIP Publishing
1 publication, 0.54%
|
|
|
Mary Ann Liebert
1 publication, 0.54%
|
|
|
World Scientific
1 publication, 0.54%
|
|
|
Japanese Society of Regenerative Medicine
1 publication, 0.54%
|
|
|
American Association for the Advancement of Science (AAAS)
1 publication, 0.54%
|
|
|
Oxford University Press
1 publication, 0.54%
|
|
|
Hindawi Limited
1 publication, 0.54%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 publication, 0.54%
|
|
|
Knowledge E DMCC
1 publication, 0.54%
|
|
|
SAGE
1 publication, 0.54%
|
|
|
10
20
30
40
50
60
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
186
Total citations:
186
Citations from 2024:
113
(60.75%)
Cite this
GOST |
RIS |
BibTex
Cite this
GOST
Copy
Akhtar A. et al. Neurodegenerative diseases and effective drug delivery: A review of challenges and novel therapeutics // Journal of Controlled Release. 2021. Vol. 330. pp. 1152-1167.
GOST all authors (up to 50)
Copy
Akhtar A., Andleeb A., Waris T. S., Bazzar M., Moradi A., Awan N. R., Yar M. Neurodegenerative diseases and effective drug delivery: A review of challenges and novel therapeutics // Journal of Controlled Release. 2021. Vol. 330. pp. 1152-1167.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/j.jconrel.2020.11.021
UR - https://doi.org/10.1016/j.jconrel.2020.11.021
TI - Neurodegenerative diseases and effective drug delivery: A review of challenges and novel therapeutics
T2 - Journal of Controlled Release
AU - Akhtar, Amna
AU - Andleeb, Anisa
AU - Waris, Tayyba Sher
AU - Bazzar, Maasoomeh
AU - Moradi, Alireza
AU - Awan, Nasir Raza
AU - Yar, Muhammad
PY - 2021
DA - 2021/02/01
PB - Elsevier
SP - 1152-1167
VL - 330
PMID - 33197487
SN - 0168-3659
SN - 1873-4995
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2021_Akhtar,
author = {Amna Akhtar and Anisa Andleeb and Tayyba Sher Waris and Maasoomeh Bazzar and Alireza Moradi and Nasir Raza Awan and Muhammad Yar},
title = {Neurodegenerative diseases and effective drug delivery: A review of challenges and novel therapeutics},
journal = {Journal of Controlled Release},
year = {2021},
volume = {330},
publisher = {Elsevier},
month = {feb},
url = {https://doi.org/10.1016/j.jconrel.2020.11.021},
pages = {1152--1167},
doi = {10.1016/j.jconrel.2020.11.021}
}